Cuvillier Verlag

Publications, Dissertations, Habilitations & Brochures.
International Specialist Publishing House for Science and Economy

Cuvillier Verlag

De En Es
The Compatibility of the Access to Essential Generic Medicines with Human Rights: An Analysis of the In-Transit Seizure of Essential Generic Medicines from India by the European Union

Hard Copy
EUR 99.90

E-book
EUR 69.90

The Compatibility of the Access to Essential Generic Medicines with Human Rights: An Analysis of the In-Transit Seizure of Essential Generic Medicines from India by the European Union (English shop)

Sanjeev Thavarajah (Author)

Preview

Extract, PDF (160 KB)
Table of Contents, PDF (100 KB)

The Covid-19 pandemic has sensitised the global community on the
importance of the access to essential medicines. The nations of the world have engaged in a fierce battle over the lifesaving Covid-19 vaccines, in which developed nations have come out successfully. The access to essential medicines has long been promoted by the United Nations (UN) and other international human rights organisations. In this context, India seems to have done its bit and has emerged as the pharmacy of the developing world and further has been providing the global poor with the advantage of access to essential as well as generic drugs.

ISBN-13 (Hard Copy) 9783736979017
ISBN-13 (eBook) 9783736969018
Language English
Page Number 412
Lamination of Cover matt
Edition 1
Publication Place Göttingen
Publication Date 2023-10-20
General Categorization Non-Fiction
Departments Law
Economics
Social sciences
Theoretical medicine
Pharmacy
Keywords generische Arzneimittel; In-Transit-Beschlagnahme; Urheberrecht ; Indien; Europäische Union; Recht auf Gesundheit; Evergreening; Zwangslizenzen; GATT; Patent- und Markenamt der Vereinigten Staaten; TRIPS; Bayer Corporation; Traditionelles Wissen; Freihandelsabkommen; Protektionismus; SARS-CoV-2; United States Patent Act; Biopiraterie; Welthandelsorganisation; WIPO; Brexit; Multilateralismus; Covid-19-Pandemie; Internationale Menschenrechte; EU Verordnung 1383/2003; Pharmazeutika; HIV/AIDS; Gomutra, Corona-Virus; Weltgesundheitsorganisation; Anti-Krebs-Therapie; Losartan; Herstellungsfiktion; Doha-Erklärung; antimikrobielle Resistenz; antiretrovirale Medikamente; Lex Specialis ; Berufungsgremium der Welthandelsorganisation; Normenkonflikt; Parallelimporte